Anti-inflammatory and anticancer effects of polysaccharides from Antrodia cinnamomea : A review
- PMID: 39467830
- DOI: 10.1097/JCMA.0000000000001186
Anti-inflammatory and anticancer effects of polysaccharides from Antrodia cinnamomea : A review
Abstract
Antrodia cinnamomea ( Ac ), also known as "Niu-Chang-Chih" in Chinese, is a valuable fungus that has been widely used as medicine and food among indigenous people in Taiwan. Ac is rich in polysaccharides ( Ac -PS), making it a promising candidate for adjunctive therapy in cancer and inflammation conditions. There are two types of Ac -PS: general (non-sulfated) PS ( Ac -GPS) and sulfated PS ( Ac -SPS). This review highlights that both Ac -GPS and Ac -SPS possess immunomodulatory, anti-inflammatory, and anticancer properties. Each type influences interleukin signaling pathways to exert its anti-inflammatory effects. Ac -GPS is particularly effective in alleviating inflammation in the brain and liver, while Ac -SPS shows its efficacy in macrophage models. Both Ac -GSP and Ac -SPS have demonstrated anticancer effects supported by in vitro and in vivo studies, primarily through inducing apoptosis in various cancer cell lines. They may also synergize with chemotherapy and exhibit antiangiogenic properties. Notably, Ac -SPS appears to have superior anticancer efficacy, potentially due to its sulfate groups. Furthermore, Ac -SPS has been more extensively studied in terms of its mechanisms and effects on lung cancer compared with Ac -GPS, highlighting its significance in cancer research. In addition, Ac -SPS is often reported for its ability to activate macrophage-mediated responses. Clinically, Ac -GPS has been used as an adjunctive therapy for advanced lung cancer, as noted in recent reports. However, given the numerous studies emphasizing its anticancer mechanisms, Ac -SPS may exhibit greater efficacy, warranting further investigation. This review concludes that Ac -derived Ac -GPS or Ac -SPS have the potential to be developed into functional health supplements or adjunctive therapies, providing dual benefits of anti-inflammatory and anticancer effects.
Copyright © 2024, the Chinese Medical Association.
Conflict of interest statement
Conflicts of interest: The authors declare that they have no conflicts of interest related to the subject matter or materials discussed in this article.
References
-
- Wu SH, Kirk P, Redhead S, Stalpers J, Dai YC, Norvell L, et al. Resolution of the nomenclature for niu-chang-chih ( Taiwanofungus camphoratus ), an important medicinal polypore. Taxon 2012;61:1305–10.
-
- Tee PYE, Krishnan T, Cheong XT, Maniam SAP, Looi CY, Ooi YY, et al. A review on the cultivation, bioactive compounds, health-promoting factors and clinical trials of medicinal mushrooms Taiwanofungus camphoratus , Inonotus obliquus and Tropicoporus linteus . Fungal Biol Biotechnol 2024;11:7–45.
-
- Ao ZH, Xu ZH, Lu ZM, Xu HY, Zhang XM, Dou WF. Niuchangchih ( Antrodia camphorata ) and its potential in treating liver diseases. J Ethnopharmacol 2009;121:194–212.
-
- Chen HP, Lee TY, Chao WW. Pharmacological activities of bioactive compounds from Taiwanofugus camphoratus . J Chin Med 2020;31:1–27.
-
- Cheng JJ, Yang CJ, Cheng CH, Wang YT, Huang NK, Lu MK. Characterization and functional study of Antrodia camphorata lipopolysaccharide. J Agric Food Chem 2005;53:469–74.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
